Medicare Enrolled
Dr. Frank Morocco, D.O.
Dermatology · Marion, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Morocco from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Morocco?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Morocco
Dr. Frank Morocco is a dermatology specialist in Marion, OH, with 17 years of NPI registration. Based on federal Medicare data, Dr. Morocco performed 5,876 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Morocco received a total of $172,222 from 44 pharmaceutical and/or device companies across 1155 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Morocco is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 12% volume in OH
$172,222 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,876
Medicare services
Top 12% in OH for dermatology
Not available
Unique patients (not deduplicated)
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,335 | $5 | $21 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,153 | $61 | $126 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
822 | $38 | $234 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
293 | $73 | $317 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
262 | $54 | $284 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
242 | $77 | $189 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
241 | $85 | $187 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
91 | $221 | $891 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
69 | $107 | $291 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
59 | $1 | $4 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
48 | $35 | $154 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
40 | $94 | $717 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
34 | $108 | $816 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 32 | $222 | $895 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $41 | $76 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
30 | $103 | $791 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
23 | $49 | $130 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
17 | $114 | $510 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
15 | $128 | $603 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
14 | $55 | $303 |
| Intermediate wound repair, 2.6-7.5 cm This procedure involves stitching a wound on the neck, hands, feet, or genitals that measures between 2.6 and 7.5 centimeters. It is classified as an intermediate repair requiring layered closure. |
13 | $239 | $849 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
12 | $66 | $472 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$172,222
Total received (2018-2024)
Avg $24,603/year across 7 years
Top 4% in OH for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
1,155
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$70,866
2023
$15,625
2022
$13,948
2021
$6,356
2020
$1,568
2019
$23,491
2018
$40,368
Payments by company (2024)
Amgen Inc.
$21,378
PFIZER INC.
$17,663
ABBVIE INC.
$11,717
Galderma Laboratories, L.P.
$9,105
Novartis Pharmaceuticals Corporation
$3,554
GENZYME CORPORATION
$3,363
Janssen Biotech, Inc.
$1,780
Dermavant Sciences, Inc.
$625
Lilly USA, LLC
$334
Regeneron Healthcare Solutions, Inc.
$232
E.R. Squibb & Sons, L.L.C.
$206
Arcutis Biotherapeutics, Inc.
$198
UCB, Inc.
$145
SUN PHARMACEUTICAL INDUSTRIES INC.
$142
Incyte Corporation
$142
LEO Pharma Inc.
$57
Ortho Dermatologics, a division of Bausch Health US, LLC
$57
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
Almirall LLC
$37
Verrica Pharmaceuticals Inc.
$34
MAYNE PHARMA COMMERCIAL LLC
$33
Genentech USA, Inc.
$17
Top 3 companies account for 71.6% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$58,262
Amgen Inc.
$29,127
Novartis Pharmaceuticals Corporation
$26,603
Galderma Laboratories, L.P.
$21,265
ABBVIE INC.
$13,055
GENZYME CORPORATION
$6,657
Pfizer Inc.
$4,293
Janssen Biotech, Inc.
$2,658
UCB, Inc.
$1,617
Dermavant Sciences, Inc.
$1,385
Lilly USA, LLC
$1,022
AbbVie, Inc.
$953
Regeneron Healthcare Solutions, Inc.
$682
Ortho Dermatologics, a division of Bausch Health US, LLC
$547
E.R. Squibb & Sons, L.L.C.
$450
Sun Pharmaceutical Industries Inc.
$438
AbbVie Inc.
$427
LEO Pharma Inc.
$316
Genentech USA, Inc.
$290
Incyte Corporation
$265
Arcutis Biotherapeutics, Inc.
$264
Almirall LLC
$229
Mayne Pharma Inc.
$194
SUN PHARMACEUTICAL INDUSTRIES INC.
$192
Taro Pharmaceuticals USA, Inc.
$140
Celgene Corporation
$126
Boehringer Ingelheim Pharmaceuticals, Inc.
$106
SANOFI-AVENTIS U.S. LLC
$89
MAYNE PHARMA COMMERCIAL LLC
$79
VYNE Pharmaceuticals Inc.
$70
PruGen, Inc. Pharmaceuticals
$64
EPI Health, LLC
$52
Merck Sharp & Dohme Corporation
$44
TARO PHARMACEUTICALS USA, INC.
$40
Promius Pharma LLC
$37
Verrica Pharmaceuticals Inc.
$34
MAYNE PHARMA INC.
$30
Encore Dermatology Inc.
$29
Sandoz Inc.
$20
Fresenius Kabi USA, LLC
$18
Journey Medical Corporation
$15
Helsinn Therapeutics (U.S.), Inc.
$14
Smith+Nephew, Inc.
$13
Genentech, Inc.
$13
Top 3 companies account for 66.2% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMZEEQ · ARAZLO · Absorica LD · Aczone · BRYHALI · Bimzelx · CIBINQO · CLODERM · COSENTYX · CYLTEZO · Cabtreo · Cimzia · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ELIDEL · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Erivedge · HALOG (Halcinonide Cream · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · HYRIMOZ · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · Klisyri · LIBTAYO · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Odomzo · Otezla · REMICADE · RETIN-A-MICRO · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Santyl · Sernivo Spray · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · Tremfya · ULTRAVATE · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · VALCHLOR · VTAMA · Winlevi · XELJANZ · Xolair · YCANTH · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
4
County median income
$57,306
Nearest hospital to ZIP centroid (approximate)
MARION GENERAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Morocco is a clinical cardiology specialist, with above-average Medicare volume (top 12% in OH), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Morocco experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Morocco performed 2,335 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Morocco receive payments from pharmaceutical companies?
Yes. Dr. Morocco received a total of $172,222 from 44 companies across 1,155 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Morocco's costs compare to other dermatologists in Marion?
Dr. Morocco's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Morocco) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Marion
Browse dermatologists in Marion ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in OH
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in OH
Which OH dermatologists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology